Consistent with a previous report showing that the NLRP3 inflammasome is activated in patient-derived cell lines and microglia17, we found that the mRNA levels of NLRC4 were significantly elevated in glioma patients (see Supplementary Fig. S1g). The gene discussed is NLRP3; the disease is central nervous system cancer.